https://platform.bgmvo.org/file/annual-financial-report-and-bgmvo-activity-report-for-2020/https://platform.bgmvo.org/file/annual-financial-report-and-bgmvo-activity-report-for-2021/https://platform.bgmvo.org/file/annual-financial-report-and-bgmvo-activity-report-for-2022/https://platform.bgmvo.org/file/general-terms-and-conditions/https://platform.bgmvo.org/file/summary-note-verification-fees-in-2023/https://platform.bgmvo.org/file/appendix-1-definitions/https://platform.bgmvo.org/file/appendix-2-financial-terms-and-conditions/https://platform.bgmvo.org/file/annex-to-the-individual-agreement-of-mah-in-force-from-01-january-2023-template/https://platform.bgmvo.org/file/individual-agreement-for-mah-connected-after-01-january-2023-template/https://platform.bgmvo.org/file/bulgarian-medicines-verification-system-bgmvs-portal-user-guide-for-end-users/https://platform.bgmvo.org/file/statute-of-bgmvo/https://platform.bgmvo.org/file/511/https://platform.bgmvo.org/file/514/https://platform.bgmvo.org/file/%d0%be%d0%b1%d1%89%d0%b8-%d1%83%d1%81%d0%bb%d0%be%d0%b2%d0%b8%d1%8f-%d0%bd%d0%b0-%d0%b1%d0%be%d0%b2%d0%bb-%d0%b7%d0%b0-%d0%bf%d0%be%d0%bb%d0%b7%d0%b2%d0%b0%d0%bd%d0%b5-%d0%bd%d0%b0-%d0%bd%d0%b0%d1%86/https://platform.bgmvo.org/file/%d0%b8%d1%82-%d0%b4%d0%be%d1%81%d1%82%d0%b0%d0%b2%d1%87%d0%b8%d1%86%d0%b8-%d0%bf%d1%80%d0%b5%d0%b4%d0%bb%d0%b0%d0%b3%d0%b0%d1%89%d0%b8-%d1%81%d0%be%d1%84%d1%82%d1%83%d0%b5%d1%80%d0%bd%d0%b8-%d1%80/https://platform.bgmvo.org/file/confidentiality-agreement/https://platform.bgmvo.org/file/guidelines-for-pharmaceutical-manufacturers-marketing-authorisation-holders-on-managing-alerts-generated-in-the-verification-and-decommissioning-of-medicinal-products-in-the-bgmvs/https://platform.bgmvo.org/file/%d0%b8%d0%bd%d1%81%d1%82%d1%80%d1%83%d0%ba%d1%86%d0%b8%d0%b8-%d0%ba%d1%8a%d0%bc-%d1%82%d1%8a%d1%80%d0%b3%d0%be%d0%b2%d1%86%d0%b8%d1%82%d0%b5-%d0%bd%d0%b0-%d0%b5%d0%b4%d1%80%d0%be-%d0%b8-%d0%b4%d1%80/https://platform.bgmvo.org/file/%d0%b7%d0%b0%d0%ba%d0%be%d0%bd-%d0%b7%d0%b0-%d0%bb%d0%b5%d0%ba%d0%b0%d1%80%d1%81%d1%82%d0%b2%d0%b5%d0%bd%d0%b8%d1%82%d0%b5-%d0%bf%d1%80%d0%be%d0%b4%d1%83%d0%ba%d1%82%d0%b8-%d0%b2-%d1%85%d1%83%d0%bc/https://platform.bgmvo.org/file/%d0%bd%d0%b0%d1%80%d0%b5%d0%b4%d0%b1%d0%b0-%e2%84%96-39-%d0%be%d1%82-13-%d1%81%d0%b5%d0%bf%d1%82%d0%b5%d0%bc%d0%b2%d1%80%d0%b8-2007-%d0%b3-%d0%b7%d0%b0-%d0%bf%d1%80%d0%b8%d0%bd%d1%86%d0%b8%d0%bf/https://platform.bgmvo.org/file/directive-2011-62-%d0%b5u/https://platform.bgmvo.org/file/commission-delegated-regulation-eu-2016_161/https://platform.bgmvo.org/file/questions-and-answers-safety-features-for-medicinal-products-for-human-use-version-19-english/https://platform.bgmvo.org/file/%d0%b8%d0%bd%d1%81%d1%82%d1%80%d1%83%d0%ba%d1%86%d0%b8%d0%b8-%d0%ba%d1%8a%d0%bc-%d1%82%d1%8a%d1%80%d0%b3%d0%be%d0%b2%d1%86%d0%b8%d1%82%d0%b5-%d0%bd%d0%b0-%d0%b5%d0%b4%d1%80%d0%be-%d0%b8-%d0%b4%d1%80-2/https://platform.bgmvo.org/file/criteria-for-exemption-of-mah-for-orphan-drugs-from-the-annual-fee-to-bgmvo/https://platform.bgmvo.org/file/emvo-on-boarding-nmvo-contracting/https://platform.bgmvo.org/file/european-pack-coding-guideline-version-4-0-july-2017/https://platform.bgmvo.org/file/data-matrix-a-solution-to-counterfeiting-of-medicines-and-in-the-service-of-traceability/https://platform.bgmvo.org/file/599/https://platform.bgmvo.org/file/602/https://platform.bgmvo.org/file/606/https://platform.bgmvo.org/file/609/https://platform.bgmvo.org/file/612/https://platform.bgmvo.org/file/presentation-european-medicines-verification-organisation-mah-on-boarding/https://platform.bgmvo.org/file/%d0%bf%d1%80%d0%b5%d0%b7%d0%b5%d0%bd%d1%82%d0%b0%d1%86%d0%b8%d1%8f-%d1%81%d1%82%d0%b0%d0%bd%d0%b4%d0%b0%d1%80%d1%82%d0%b8%d1%82%d0%b5-gs1-%d1%84%d0%b8%d1%80%d0%bc%d0%b5%d0%bd%d0%b8%d1%82/https://platform.bgmvo.org/file/%d0%b8%d0%bd%d1%84%d0%be%d1%80%d0%bc%d0%b0%d1%86%d0%b8%d0%be%d0%bd%d0%bd%d0%b0-%d0%bb%d0%b8%d1%81%d1%82%d0%be%d0%b2%d0%ba%d0%b0-%d0%b7%d0%b0-%d0%bf%d0%b0%d1%86%d0%b8%d0%b5%d0%bd%d1%82%d0%b0/https://platform.bgmvo.org/file/675/https://platform.bgmvo.org/file/686/https://platform.bgmvo.org/file/annual-financial-report-and-bgmvo-activity-report-for-2023/https://platform.bgmvo.org/file/737/https://platform.bgmvo.org/file/summary-note-verification-fees-in-2026/https://platform.bgmvo.org/file/general-terms-and-conditions-3/https://platform.bgmvo.org/file/appendix-1-definitions-3/https://platform.bgmvo.org/file/appendix-2-financial-terms-and-conditions-3/https://platform.bgmvo.org/file/individual-agreement-for-mah-connected-after-01-january-2026-template/https://platform.bgmvo.org/file/annex-to-the-individual-agreement-of-mah-in-force-from-01-january-2026-template/https://platform.bgmvo.org/file/bgmvo-newsletter-2026/https://platform.bgmvo.org/file/%d1%83%d0%ba%d0%b0%d0%b7%d0%b0%d0%bd%d0%b8%d1%8f-%d0%b7%d0%b0-%d1%81%d0%b2%d1%8a%d1%80%d0%b7%d0%b2%d0%b0%d0%bd%d0%b5-%d1%81-bgmvs/